Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV

Home › Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV

No product-specific concern identified for Suvaxyn PRRS MLV and benefit/risk balance for the product remains favourable.

26.11	New swine respiratory disease treatment flexibility from nursery to finish
26.11	Panel talks capturing added value in cattle
26.11	AMS extends comment period on fed cattle market rule
26.11	When to start grazing wheat pasture?
26.11	RaboResearch: Productivity and efficiency will power the next U.S. cow herd rebuild
26.11	Study reveals vast majority of feed outages due to bin slide management mistakes
26.11	EPA releases draft farm emissions methodologies
26.11	USDA Air Quality Task Force taps two from pork industry
Agriculture and Forestry »

je.st